Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.051 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |